Walsuralactam A in the formula I, which is used as an active ingredient, and is used for treating and preventing the tumour.

1370556-82-3

C26H31NO5

437.53

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years